Ahead of speaking at Rewired 2025, Mike Fell, executive director of national cyber security operations at NHSE, sat down with Digital Health.

Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...

Food Certification Market Growing consumer demand for transparency, food quality, and safety drives food producers to obtain certificati ...

Aurinia Pharmaceuticals Inc. (Aurinia or the Company) commends the American College of Rheumatology (ACR) for their 2024 evidence-based guidelines for the screening, treatment, and management of lupus ...

In today’s fast-paced digital world, managing our identities and crucial documents can feel like a juggling act—one misstep, ...

Ipsen presents three late-breaking presentations and eight abstracts across rare cholestatic liver disease portfolio at AASLD 2024Elafibranor was granted marketing authorisation for the treatment of ...

The Collaborative Group of the Americas – Inherited Gastrointestinal Cancers (CGA-IGC) was established in 1995 to improve understanding of the basic science and clinical management of inherited ... a ...

An analysis of pancreatic cancer data in younger adults found that while there is an increasing incidence of pancreatic cancer in young adults, the mortality rate remains stable.

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

Palantir Technologies Inc. has renewed its multi-year enterprise agreement with the Rio Tinto Group, one of the world's leading mining and metals groups . The agreement extends the enterprise ...

The global Internet of Things on Insurance market is expected to grow from 13 Billion USD in 2023 to 45 Billion USD by 2032, with a CAGR of 15% ...

New insights and emerging scientific trends incorporated into our ACLF development plan, with data readout from 4 clinical trials anticipated by the end of 2025, including data from 3 new clinical ...